Tooman Craig A

Tooman Craig A is listed in filings as President and CEO at Silence Therapeutics plc. This profile follows SEC Form 4 activity through Jan 6, 2025, including 1 public disclosure. Recent filings connect the profile to Silence Therapeutics plc (SLN). The current snapshot covers public activity from Jan 6, 2025. Reported amounts are shown as $2.2M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.